- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Having The Snooze Blues? State Of The Science On Sleep In Mood Disorders
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Having The Snooze Blues? State Of The Science On Sleep In Mood Disorders
Sleep disturbance is a predominant symptom associated with depression, impacting ~75% of those diagnosed with depression. Insomnia, hypersomnia, and obstructive sleep apnea are all highly prevalent among those with depression.1 An estimated 40% of individuals among the general and healthcare populations have reported sleep problems because of the COVID pandemic, with certain gender and ethnic groups being impacted at a disproportionate rate.2 Given the positive correlation between sleep disturbances and depression, this has raised concerns among experts for the potential development of mood disorders more broadly across our society.
In this webinar, Dr. Beth DiNapoli moderates an enlightening discussion on the current state of the science in sleep and depression with experts in psychiatry and sleep, Drs. Vladimir Maletic and Marie Anne Gebara. They will reflect on scientific advances in understanding the complex, bidirectional relationship between sleep disturbances and depression, as well as the potential long-term impact of the SARS-CoV-2 pandemic on sleep quality and mood disorders. Educational and supportive resources for improving sleep hygiene will be provided. Join us for this unique opportunity to learn and grow as we all strive to improve our quality of life in this para-pandemic world!
References:
- Newsom R. www.sleepfoundation.org/mental-health/depression-and-sleep. Accessed on November 2021.
- Mandelkorn U, et al. Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study. J Clin Sleep Med. 2021;17(1):45–53.
Featuring
-
Vladimir Maletic, MD, MS
Clinical Professor, Psychiatry/Behavioral Science, School of Medicine Greenville, SC; Rated Best Doctors of America Registry, Psychiatrist of the year, Upjohn Achievement Award, Student Council teaching award and faculty award for teaching achievement, as well as Medical School Award for Academic Achievement
-
Marie Anne Gebara, MD
Assistant Professor of Psychiatry, University of Pittsburgh
-
Elizabeth DiNapoli, PhD (OPDC)
Senior Clinical & Scientific Liaison
Vladimir Maletic, MD, MS and Marie Anne Gebara, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Beth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
What’s New, Going Away, & Here To Stay: A Look Forward From The OPEN MINDS & Otsuka National Payer Survey
May 31 12:00 pm to 1:00 pm
Registration
Related Resources
-
Re-Imagining The Dopamine Hypothesis Of Schizophrenia: How Can We Find A Balance?
On-Demand Webinar May 24, 2022The dopamine hypothesis of schizophrenia has been foundational in elucidating the benefit of dopamine-blocking actions of antipsychotic medications over the past 60 years. Although blocking the D2 receptors may lead…
-
16% Of Community Mental Health Centers Use Measurement-Based Care, Despite Knowledge Of Value
Article May 23, 2022As of October 2021, 83% of community mental health center (CMHC) executives said that “their organization is familiar with the value of using measurement-based care (MBC)”, however just 16% were…
-
New Florida Law Exempts Antipsychotics From Medicaid Step Therapy
Article May 23, 2022On April 6, 2022, Florida enacted a bill to exempt Medicaid beneficiaries diagnosed with schizophrenia from step-therapy authorizations for antipsychotic medications. Under the new law, the beneficiary can be exempted…
Stay Connected:
- Resource Library